SCHEMBL4473412

SCHEMBL4473412

c1cnn(-c2ccncc2)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.63
KDM4E B2RXH2 3/20 0.57
ALDH1A1 P00352 3/20 0.57
MAPK1 P28482 2/20 0.57
CHRNA7 P36544 1/20 0.44
CHRNA10 Q9GZZ6 1/20 0.44
CHRNA9 Q9UGM1 1/20 0.44
MEN1 O00255 3/20 0.43
MAPT P10636 3/20 0.43
KMT2A Q03164 3/20 0.43
LMNA P02545 2/20 0.43
GAA P10253 1/20 0.43
G6PD P11413 1/20 0.43
DRD2 P14416 1/20 0.42
DRD4 P21917 1/20 0.42
DRD3 P35462 1/20 0.42
NPC1 O15118 1/20 0.42
TBK1 Q9UHD2 1/20 0.41
HDAC4 P56524 1/20 0.41
CHRM1 P11229 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL16827815 0.98 NOTUM (0.61) NOTUMKDM4EALDH1A1MAPK1CHRNA7
SCHEMBL4341894 0.87 NOTUM (0.78) NOTUMKDM4EALDH1A1MAPK1CHRNA7
Pyridine SCHEMBL28534733 0.85 NOTUM (0.57) NOTUMKDM4EALDH1A1MAPK1CHRNA7
SCHEMBL27250 0.83 NOTUM (0.65) NOTUMKDM4EALDH1A1MAPK1CHRNA7
SCHEMBL16549641 0.82 KDM4E (0.64) NOTUMKDM4EALDH1A1MAPK1CHRNA7
SCHEMBL514704 0.81 NOTUM (0.63) NOTUMKDM4EALDH1A1MAPK1CHRNA7
SCHEMBL6428811 0.81 NOTUM (0.63) NOTUMKDM4EALDH1A1MAPK1CHRNA7
Hydrochloric Acid SCHEMBL15510676 0.81 NOTUM (0.63) NOTUMKDM4EALDH1A1MAPK1CHRNA7
SCHEMBL842039 0.81 NOTUM (0.63) NOTUMKDM4EALDH1A1MAPK1CHRNA7
SCHEMBL28493417 0.81 NOTUM (0.63) NOTUMKDM4EALDH1A1MAPK1CHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025076088-A1 LACTAMS FOR USE AS SARM1 INHIBITORS GENENTECH, INC. (US) 2025-04-10 WO disclosed
WO-2025040546-A1 PYRAZOLE COMPOUNDS AS CULLIN RING UBIQUITIN LIGASE COMPOUNDS PROXYGEN GMBH (AT) 2025-02-27 WO disclosed
US-20240368173-A1 TRICYCLIC GPR65 MODULATORS Pathios Therapeutics Limited (GB) 2024-11-07 US disclosed
US-20230271941-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY NOVARTIS PHARMA AG (CH) 2023-08-31 US disclosed
CN-116655699-A Bivalent platinum complex white phosphorus light material and device application thereof 南京佳诺霖光电科技有限公司 2023-08-29 CN disclosed
CN-116490503-A Casein kinase 1 delta modulators 詹森药业有限公司 2023-07-25 CN disclosed
EP-2944637-B1 NITROGEN-CONTAINING HETEROCYLIC COMPOUND OR SALT THEREOF FUJIFILM CORP (JP) 2020-02-19 EP disclosed
US-9783536-B2 Nitrogen-containing heterocyclic compound or salt thereof FUJIFILM CORPORATION (JP) 2017-10-10 US disclosed
US-9783536-B2 Nitrogen-containing heterocyclic compound or salt thereof FUJIFILM CORPORATION (JP) 2017-10-10 US disclosed
US-9783536-B2 Nitrogen-containing heterocyclic compound or salt thereof FUJIFILM CORPORATION (JP) 2017-10-10 US disclosed
CN-103327972-A Substituted benzamides and their uses UNIV LELAND STANFORD JUNIOR 2013-09-25 CN disclosed
WO-2012143144-A1 PYRAZOLO [4, 3-D] PYRIMIDINES USEFUL AS KINASE INHIBITORS ORIGENIS GMBH (DE) 2012-10-26 WO disclosed
CN-102712625-A Nitrogen-containing heteroaryl derivatives HOFFMANN LA ROCHE 2012-10-03 CN disclosed
CN-101765600-A pyrazolopyrimidinone kinase inhibitor GPC BIOTECH AG 2010-06-30 CN disclosed
US-7491737-B2 Heterarylpiperidine modulators of chemokine receptor activity MERCK & CO., INC. (US) 2009-02-17 US disclosed
US-20050250781-A1 Heterarylpiperidine modulators of chemokine receptor activity MERCK SHARP & DOHME CORP. 2005-11-10 US disclosed
EP-1142890-A1 AMINOPYRAZOLE DERIVATIVES TEIKOKU HORMONE MFG. CO., LTD. (JP) 2001-10-10 EP disclosed
EP-0159011-B1 CEPHALOSPORIN DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM DAIICHI SEIYAKU CO., LTD. (JP) 1989-08-02 EP disclosed
US-4833242-A ANTIBIOTICS, BACTERICIDES DAIICHI SEIYAKU CO., LTD. (JP) 1989-05-23 US disclosed
EP-0159011-A2 Cephalosporin derivatives, process for preparing them and pharmaceutical compositions containing them DAIICHI SEIYAKU CO., LTD. (JP) 1985-10-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240368173-A1 TRICYCLIC GPR65 MODULATORS GPR65, GPR3, NR1H2 NOTUM 4311/4885KDM4E 3978/4885ALDH1A1 2926/4885
US-20230271941-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY STING1, CGAS, IRF3 NOTUM 4501/4885KDM4E 3761/4885ALDH1A1 4654/4885
US-20050250781-A1 Heterarylpiperidine modulators of chemokine receptor activity CCR1, CCR2, CCRL2 NOTUM 3878/4885KDM4E 4493/4885ALDH1A1 1116/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.